{"id":"https://openalex.org/W2138741985","doi":"https://doi.org/10.1158/1535-7163.mct-13-0424","title":"Inhibition of Wee1 Sensitizes Cancer Cells to Antimetabolite Chemotherapeutics In Vitro and In Vivo , Independent of p53 Functionality","display_name":"Inhibition of Wee1 Sensitizes Cancer Cells to Antimetabolite Chemotherapeutics In Vitro and In Vivo , Independent of p53 Functionality","publication_year":2013,"publication_date":"2013-10-11","ids":{"openalex":"https://openalex.org/W2138741985","doi":"https://doi.org/10.1158/1535-7163.mct-13-0424","mag":"2138741985","pmid":"https://pubmed.ncbi.nlm.nih.gov/24121103","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/3897395"},"language":"en","primary_location":{"id":"doi:10.1158/1535-7163.mct-13-0424","doi":"https://doi.org/10.1158/1535-7163.mct-13-0424","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1535-7163.mct-13-0424","pdf_url":null,"source":{"id":"https://openalex.org/S48437117","display_name":"Molecular Cancer Therapeutics","issn_l":"1535-7163","issn":["1535-7163","1538-8514"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer Therapeutics","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3897395","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5008453489","display_name":"Annemie A. Van Linden","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210134151","display_name":"University of Colorado Cancer Center","ror":"https://ror.org/04cqn7d42","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210134151"]},{"id":"https://openalex.org/I51713134","display_name":"University of Colorado Anschutz","ror":"https://ror.org/03wmf1y16","country_code":"US","type":"education","lineage":["https://openalex.org/I51713134"]},{"id":"https://openalex.org/I921990950","display_name":"University of Colorado Denver","ror":"https://ror.org/02hh7en24","country_code":"US","type":"education","lineage":["https://openalex.org/I921990950"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Annemie A. Van Linden","raw_affiliation_strings":["Authors' Affiliations:Departments of 1Pediatrics and 2Medicine, University of Colorado, School of Medicine; 3University of Colorado Cancer Center; and 4Department of Pharmaceutical Sciences, University of Colorado, School of Pharmacy, Aurora, Colorado","Department of Pharmaceutical Sciences, University of Colorado, School of Pharmacy, Aurora, Colorado","University of Colorado Cancer Center"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:Departments of 1Pediatrics and 2Medicine, University of Colorado, School of Medicine; 3University of Colorado Cancer Center; and 4Department of Pharmaceutical Sciences, University of Colorado, School of Pharmacy, Aurora, Colorado","institution_ids":["https://openalex.org/I4210134151","https://openalex.org/I51713134"]},{"raw_affiliation_string":"Department of Pharmaceutical Sciences, University of Colorado, School of Pharmacy, Aurora, Colorado","institution_ids":["https://openalex.org/I921990950"]},{"raw_affiliation_string":"University of Colorado Cancer Center","institution_ids":["https://openalex.org/I4210134151"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053826232","display_name":"Dmitry Baturin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210134151","display_name":"University of Colorado Cancer Center","ror":"https://ror.org/04cqn7d42","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210134151"]},{"id":"https://openalex.org/I51713134","display_name":"University of Colorado Anschutz","ror":"https://ror.org/03wmf1y16","country_code":"US","type":"education","lineage":["https://openalex.org/I51713134"]},{"id":"https://openalex.org/I921990950","display_name":"University of Colorado Denver","ror":"https://ror.org/02hh7en24","country_code":"US","type":"education","lineage":["https://openalex.org/I921990950"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Dmitry Baturin","raw_affiliation_strings":["Authors' Affiliations:Departments of 1Pediatrics and 2Medicine, University of Colorado, School of Medicine; 3University of Colorado Cancer Center; and 4Department of Pharmaceutical Sciences, University of Colorado, School of Pharmacy, Aurora, Colorado","Department of Pharmaceutical Sciences, University of Colorado, School of Pharmacy, Aurora, Colorado","University of Colorado Cancer Center"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:Departments of 1Pediatrics and 2Medicine, University of Colorado, School of Medicine; 3University of Colorado Cancer Center; and 4Department of Pharmaceutical Sciences, University of Colorado, School of Pharmacy, Aurora, Colorado","institution_ids":["https://openalex.org/I4210134151","https://openalex.org/I51713134"]},{"raw_affiliation_string":"Department of Pharmaceutical Sciences, University of Colorado, School of Pharmacy, Aurora, Colorado","institution_ids":["https://openalex.org/I921990950"]},{"raw_affiliation_string":"University of Colorado Cancer Center","institution_ids":["https://openalex.org/I4210134151"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009053423","display_name":"James B. Ford","orcid":"https://orcid.org/0000-0001-9716-3049","observed_orcids":["https://orcid.org/0000-0001-9716-3049"]},"institutions":[{"id":"https://openalex.org/I4210134151","display_name":"University of Colorado Cancer Center","ror":"https://ror.org/04cqn7d42","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210134151"]},{"id":"https://openalex.org/I51713134","display_name":"University of Colorado Anschutz","ror":"https://ror.org/03wmf1y16","country_code":"US","type":"education","lineage":["https://openalex.org/I51713134"]},{"id":"https://openalex.org/I921990950","display_name":"University of Colorado Denver","ror":"https://ror.org/02hh7en24","country_code":"US","type":"education","lineage":["https://openalex.org/I921990950"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"James B. Ford","raw_affiliation_strings":["Authors' Affiliations:Departments of 1Pediatrics and 2Medicine, University of Colorado, School of Medicine; 3University of Colorado Cancer Center; and 4Department of Pharmaceutical Sciences, University of Colorado, School of Pharmacy, Aurora, Colorado","Department of Pharmaceutical Sciences, University of Colorado, School of Pharmacy, Aurora, Colorado","University of Colorado Cancer Center"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:Departments of 1Pediatrics and 2Medicine, University of Colorado, School of Medicine; 3University of Colorado Cancer Center; and 4Department of Pharmaceutical Sciences, University of Colorado, School of Pharmacy, Aurora, Colorado","institution_ids":["https://openalex.org/I4210134151","https://openalex.org/I51713134"]},{"raw_affiliation_string":"Department of Pharmaceutical Sciences, University of Colorado, School of Pharmacy, Aurora, Colorado","institution_ids":["https://openalex.org/I921990950"]},{"raw_affiliation_string":"University of Colorado Cancer Center","institution_ids":["https://openalex.org/I4210134151"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053681422","display_name":"Susan P. Fosmire","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210134151","display_name":"University of Colorado Cancer Center","ror":"https://ror.org/04cqn7d42","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210134151"]},{"id":"https://openalex.org/I51713134","display_name":"University of Colorado Anschutz","ror":"https://ror.org/03wmf1y16","country_code":"US","type":"education","lineage":["https://openalex.org/I51713134"]},{"id":"https://openalex.org/I921990950","display_name":"University of Colorado Denver","ror":"https://ror.org/02hh7en24","country_code":"US","type":"education","lineage":["https://openalex.org/I921990950"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Susan P. Fosmire","raw_affiliation_strings":["Authors' Affiliations:Departments of 1Pediatrics and 2Medicine, University of Colorado, School of Medicine; 3University of Colorado Cancer Center; and 4Department of Pharmaceutical Sciences, University of Colorado, School of Pharmacy, Aurora, Colorado","Department of Pharmaceutical Sciences, University of Colorado, School of Pharmacy, Aurora, Colorado","University of Colorado Cancer Center"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:Departments of 1Pediatrics and 2Medicine, University of Colorado, School of Medicine; 3University of Colorado Cancer Center; and 4Department of Pharmaceutical Sciences, University of Colorado, School of Pharmacy, Aurora, Colorado","institution_ids":["https://openalex.org/I4210134151","https://openalex.org/I51713134"]},{"raw_affiliation_string":"Department of Pharmaceutical Sciences, University of Colorado, School of Pharmacy, Aurora, Colorado","institution_ids":["https://openalex.org/I921990950"]},{"raw_affiliation_string":"University of Colorado Cancer Center","institution_ids":["https://openalex.org/I4210134151"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036275155","display_name":"Lori A. Gardner","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210134151","display_name":"University of Colorado Cancer Center","ror":"https://ror.org/04cqn7d42","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210134151"]},{"id":"https://openalex.org/I51713134","display_name":"University of Colorado Anschutz","ror":"https://ror.org/03wmf1y16","country_code":"US","type":"education","lineage":["https://openalex.org/I51713134"]},{"id":"https://openalex.org/I921990950","display_name":"University of Colorado Denver","ror":"https://ror.org/02hh7en24","country_code":"US","type":"education","lineage":["https://openalex.org/I921990950"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lori Gardner","raw_affiliation_strings":["Authors' Affiliations:Departments of 1Pediatrics and 2Medicine, University of Colorado, School of Medicine; 3University of Colorado Cancer Center; and 4Department of Pharmaceutical Sciences, University of Colorado, School of Pharmacy, Aurora, Colorado","Department of Pharmaceutical Sciences, University of Colorado, School of Pharmacy, Aurora, Colorado","University of Colorado Cancer Center"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:Departments of 1Pediatrics and 2Medicine, University of Colorado, School of Medicine; 3University of Colorado Cancer Center; and 4Department of Pharmaceutical Sciences, University of Colorado, School of Pharmacy, Aurora, Colorado","institution_ids":["https://openalex.org/I4210134151","https://openalex.org/I51713134"]},{"raw_affiliation_string":"Department of Pharmaceutical Sciences, University of Colorado, School of Pharmacy, Aurora, Colorado","institution_ids":["https://openalex.org/I921990950"]},{"raw_affiliation_string":"University of Colorado Cancer Center","institution_ids":["https://openalex.org/I4210134151"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036812326","display_name":"Christopher T. Korch","orcid":"https://orcid.org/0009-0007-4072-7983","observed_orcids":["https://orcid.org/0009-0007-4072-7983"]},"institutions":[{"id":"https://openalex.org/I4210134151","display_name":"University of Colorado Cancer Center","ror":"https://ror.org/04cqn7d42","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210134151"]},{"id":"https://openalex.org/I51713134","display_name":"University of Colorado Anschutz","ror":"https://ror.org/03wmf1y16","country_code":"US","type":"education","lineage":["https://openalex.org/I51713134"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Christopher Korch","raw_affiliation_strings":["Authors' Affiliations:Departments of 1Pediatrics and 2Medicine, University of Colorado, School of Medicine; 3University of Colorado Cancer Center; and 4Department of Pharmaceutical Sciences, University of Colorado, School of Pharmacy, Aurora, Colorado","University of Colorado Cancer Center"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:Departments of 1Pediatrics and 2Medicine, University of Colorado, School of Medicine; 3University of Colorado Cancer Center; and 4Department of Pharmaceutical Sciences, University of Colorado, School of Pharmacy, Aurora, Colorado","institution_ids":["https://openalex.org/I4210134151","https://openalex.org/I51713134"]},{"raw_affiliation_string":"University of Colorado Cancer Center","institution_ids":["https://openalex.org/I4210134151"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029491331","display_name":"Philip Reigan","orcid":"https://orcid.org/0000-0003-0346-1016","observed_orcids":["https://orcid.org/0000-0003-0346-1016"]},"institutions":[{"id":"https://openalex.org/I4210134151","display_name":"University of Colorado Cancer Center","ror":"https://ror.org/04cqn7d42","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210134151"]},{"id":"https://openalex.org/I51713134","display_name":"University of Colorado Anschutz","ror":"https://ror.org/03wmf1y16","country_code":"US","type":"education","lineage":["https://openalex.org/I51713134"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Philip Reigan","raw_affiliation_strings":["Authors' Affiliations:Departments of 1Pediatrics and 2Medicine, University of Colorado, School of Medicine; 3University of Colorado Cancer Center; and 4Department of Pharmaceutical Sciences, University of Colorado, School of Pharmacy, Aurora, Colorado","University of Colorado Cancer Center"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:Departments of 1Pediatrics and 2Medicine, University of Colorado, School of Medicine; 3University of Colorado Cancer Center; and 4Department of Pharmaceutical Sciences, University of Colorado, School of Pharmacy, Aurora, Colorado","institution_ids":["https://openalex.org/I4210134151","https://openalex.org/I51713134"]},{"raw_affiliation_string":"University of Colorado Cancer Center","institution_ids":["https://openalex.org/I4210134151"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5063321500","display_name":"Christopher C. Porter","orcid":"https://orcid.org/0000-0001-8774-0180","observed_orcids":["https://orcid.org/0000-0001-8774-0180"]},"institutions":[{"id":"https://openalex.org/I4210134151","display_name":"University of Colorado Cancer Center","ror":"https://ror.org/04cqn7d42","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210134151"]},{"id":"https://openalex.org/I51713134","display_name":"University of Colorado Anschutz","ror":"https://ror.org/03wmf1y16","country_code":"US","type":"education","lineage":["https://openalex.org/I51713134"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Christopher C. Porter","raw_affiliation_strings":["Authors' Affiliations:Departments of 1Pediatrics and 2Medicine, University of Colorado, School of Medicine; 3University of Colorado Cancer Center; and 4Department of Pharmaceutical Sciences, University of Colorado, School of Pharmacy, Aurora, Colorado","University of Colorado Cancer Center"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:Departments of 1Pediatrics and 2Medicine, University of Colorado, School of Medicine; 3University of Colorado Cancer Center; and 4Department of Pharmaceutical Sciences, University of Colorado, School of Pharmacy, Aurora, Colorado","institution_ids":["https://openalex.org/I4210134151","https://openalex.org/I51713134"]},{"raw_affiliation_string":"University of Colorado Cancer Center","institution_ids":["https://openalex.org/I4210134151"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5063321500"],"corresponding_institution_ids":["https://openalex.org/I4210134151","https://openalex.org/I51713134"],"apc_list":null,"apc_paid":null,"fwci":4.6442,"has_fulltext":false,"cited_by_count":127,"citation_normalized_percentile":{"value":0.95570354,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":97,"max":100},"biblio":{"volume":"12","issue":"12","first_page":"2675","last_page":"2684"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10583","display_name":"Cancer-related Molecular Pathways","score":0.9843999743461609,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10583","display_name":"Cancer-related Molecular Pathways","score":0.9843999743461609,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.006300000008195639,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10492","display_name":"Microtubule and mitosis dynamics","score":0.0013000000035390258,"subfield":{"id":"https://openalex.org/subfields/1307","display_name":"Cell Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/wee1-inhibition","display_name":"WEE1 inhibition","score":0.9860000014305115},{"id":"https://openalex.org/keywords/mk-1775","display_name":"MK-1775","score":0.9909999966621399},{"id":"https://openalex.org/keywords/cytarabine","display_name":"cytarabine","score":0.9409999847412109},{"id":"https://openalex.org/keywords/antimetabolite-chemotherapy","display_name":"antimetabolite chemotherapy","score":0.7950000166893005},{"id":"https://openalex.org/keywords/chemosensitization","display_name":"chemosensitization","score":0.9089999794960022},{"id":"https://openalex.org/keywords/p53-dysfunction","display_name":"p53 dysfunction","score":0.8029999732971191},{"id":"https://openalex.org/keywords/acute-myeloid-leukemia","display_name":"acute myeloid leukemia","score":0.9490000009536743},{"id":"https://openalex.org/keywords/lung-cancer","display_name":"lung cancer","score":0.8799999952316284},{"id":"https://openalex.org/keywords/intra-s-phase-checkpoint","display_name":"S-phase checkpoint","score":0.9710000157356262},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.9879999756813049},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.7870000004768372},{"id":"https://openalex.org/keywords/predictive-biomarkers","display_name":"predictive biomarkers","score":0.9629999995231628}],"concepts":[{"id":"https://openalex.org/C2778041864","wikidata":"https://www.wikidata.org/wiki/Q180983","display_name":"Cytarabine","level":3,"score":0.8664931058883667},{"id":"https://openalex.org/C2778397455","wikidata":"https://www.wikidata.org/wiki/Q50429865","display_name":"Antimetabolite","level":3,"score":0.7320507764816284},{"id":"https://openalex.org/C2781252693","wikidata":"https://www.wikidata.org/wiki/Q7979264","display_name":"Wee1","level":5,"score":0.7115156650543213},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5929283499717712},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.521252453327179},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.474553644657135},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3991543650627136},{"id":"https://openalex.org/C2778729363","wikidata":"https://www.wikidata.org/wiki/Q11688946","display_name":"Myeloid leukemia","level":2,"score":0.37731099128723145},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3675655126571655},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.2915177345275879},{"id":"https://openalex.org/C29537977","wikidata":"https://www.wikidata.org/wiki/Q188941","display_name":"Cell cycle","level":3,"score":0.25971412658691406},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.251120388507843},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.17363807559013367},{"id":"https://openalex.org/C120504264","wikidata":"https://www.wikidata.org/wiki/Q1147372","display_name":"Cyclin-dependent kinase 1","level":4,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000964","descriptor_name":"Antimetabolites, Antineoplastic","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000964","descriptor_name":"Antimetabolites, Antineoplastic","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000964","descriptor_name":"Antimetabolites, Antineoplastic","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D004357","descriptor_name":"Drug Synergism","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004357","descriptor_name":"Drug Synergism","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004357","descriptor_name":"Drug Synergism","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009687","descriptor_name":"Nuclear Proteins","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D009687","descriptor_name":"Nuclear Proteins","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D009687","descriptor_name":"Nuclear Proteins","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D011505","descriptor_name":"Protein-Tyrosine Kinases","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D011505","descriptor_name":"Protein-Tyrosine Kinases","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D011505","descriptor_name":"Protein-Tyrosine Kinases","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D011720","descriptor_name":"Pyrazoles","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D011720","descriptor_name":"Pyrazoles","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D011720","descriptor_name":"Pyrazoles","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D011744","descriptor_name":"Pyrimidinones","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011744","descriptor_name":"Pyrimidinones","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011744","descriptor_name":"Pyrimidinones","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015470","descriptor_name":"Leukemia, Myeloid, Acute","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D015470","descriptor_name":"Leukemia, Myeloid, Acute","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D015470","descriptor_name":"Leukemia, Myeloid, Acute","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D015470","descriptor_name":"Leukemia, Myeloid, Acute","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D015470","descriptor_name":"Leukemia, Myeloid, Acute","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D015470","descriptor_name":"Leukemia, Myeloid, Acute","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D015470","descriptor_name":"Leukemia, Myeloid, Acute","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":false},{"descriptor_ui":"D015470","descriptor_name":"Leukemia, Myeloid, Acute","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":false},{"descriptor_ui":"D015470","descriptor_name":"Leukemia, Myeloid, Acute","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":false},{"descriptor_ui":"D016159","descriptor_name":"Tumor Suppressor Protein p53","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D016159","descriptor_name":"Tumor Suppressor Protein p53","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D016159","descriptor_name":"Tumor Suppressor Protein p53","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D017209","descriptor_name":"Apoptosis","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D017209","descriptor_name":"Apoptosis","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D017209","descriptor_name":"Apoptosis","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D018797","descriptor_name":"Cell Cycle Proteins","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D018797","descriptor_name":"Cell Cycle Proteins","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D018797","descriptor_name":"Cell Cycle Proteins","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D019008","descriptor_name":"Drug Resistance, Neoplasm","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019008","descriptor_name":"Drug Resistance, Neoplasm","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019008","descriptor_name":"Drug Resistance, Neoplasm","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D023041","descriptor_name":"Xenograft Model Antitumor Assays","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D023041","descriptor_name":"Xenograft Model Antitumor Assays","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D023041","descriptor_name":"Xenograft Model Antitumor Assays","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D059447","descriptor_name":"Cell Cycle Checkpoints","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D059447","descriptor_name":"Cell Cycle Checkpoints","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D059447","descriptor_name":"Cell Cycle Checkpoints","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1158/1535-7163.mct-13-0424","doi":"https://doi.org/10.1158/1535-7163.mct-13-0424","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1535-7163.mct-13-0424","pdf_url":null,"source":{"id":"https://openalex.org/S48437117","display_name":"Molecular Cancer Therapeutics","issn_l":"1535-7163","issn":["1535-7163","1538-8514"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer Therapeutics","raw_type":"journal-article"},{"id":"pmid:24121103","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/24121103","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular cancer therapeutics","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:3897395","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3897395","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Mol Cancer Ther","raw_type":"Text"}],"best_oa_location":{"id":"pmh:oai:pubmedcentral.nih.gov:3897395","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3897395","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Mol Cancer Ther","raw_type":"Text"},"sustainable_development_goals":[{"score":0.9537000060081482,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[{"score":0.8299999833106995,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G2677559403","display_name":"Validation and Development of WEE1 as a therapeutic target in AML","funder_award_id":"R01CA172385","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G3352185070","display_name":"Post Graduate Training in Pediatric Oncology","funder_award_id":"T32CA082086","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G9000891461","display_name":"University of Colorado Cancer Center Support Grant","funder_award_id":"P30CA046934","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320332932","display_name":"Merck Sharp and Dohme","ror":"https://ror.org/004nn4n27"},{"id":"https://openalex.org/F4320332965","display_name":"University of Colorado Denver","ror":"https://ror.org/02hh7en24"},{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"},{"id":"https://openalex.org/F4320337586","display_name":"Hyundai Hope On Wheels","ror":"https://ror.org/01f6q3121"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":28,"referenced_works":["https://openalex.org/W1558366281","https://openalex.org/W1967297795","https://openalex.org/W1997707998","https://openalex.org/W2002954014","https://openalex.org/W2027855079","https://openalex.org/W2028495676","https://openalex.org/W2035263093","https://openalex.org/W2036281060","https://openalex.org/W2038143768","https://openalex.org/W2042740031","https://openalex.org/W2072544833","https://openalex.org/W2077813812","https://openalex.org/W2077945404","https://openalex.org/W2079296353","https://openalex.org/W2093938238","https://openalex.org/W2096293110","https://openalex.org/W2097173890","https://openalex.org/W2097803438","https://openalex.org/W2097933346","https://openalex.org/W2099540110","https://openalex.org/W2100494757","https://openalex.org/W2111222453","https://openalex.org/W2125568481","https://openalex.org/W2135535670","https://openalex.org/W2142325694","https://openalex.org/W2155836153","https://openalex.org/W2163018106","https://openalex.org/W2235427389"],"related_works":["https://openalex.org/W2320105603","https://openalex.org/W2504357924","https://openalex.org/W2096293110","https://openalex.org/W2766341592","https://openalex.org/W2605262538","https://openalex.org/W2340341147","https://openalex.org/W2083096075","https://openalex.org/W4416643687","https://openalex.org/W2137047315","https://openalex.org/W2340117521"],"abstract_inverted_index":{"Inhibition":[0],"of":[1,76,100,108,129,155,169,175,197],"Wee1":[2,25,41,56,66,80,109,141,176,207],"is":[3,58,68,189],"emerging":[4],"as":[5,200],"a":[6,79,201],"novel":[7],"therapeutic":[8],"strategy":[9],"for":[10,204,222],"cancer,":[11],"and":[12,37,63,70,86,114,122,157,164,179,225],"some":[13],"data":[14,218],"suggest":[15],"that":[16,40,106,194],"cells":[17,45],"with":[18,28,33,78,140,145,149,229],"dysfunctional":[19],"p53":[20,61,101,130,188,198],"are":[21],"more":[22],"sensitive":[23],"to":[24,46,51,138,184,206,212],"inhibition":[26,42,57,67,75,107,174,208],"combined":[27],"conventional":[29],"chemotherapy":[30],"than":[31],"those":[32],"functional":[34,190],"p53.":[35],"We":[36],"others":[38],"found":[39],"sensitizes":[43,177],"leukemia":[44,94],"cytarabine.":[47,119],"Thus,":[48,173],"we":[49],"sought":[50],"determine":[52],"whether":[53,64,187],"chemosensitization":[54],"by":[55,118],"dependent":[59],"on":[60],"dysfunction":[62],"combining":[65],"tolerable":[69],"effective":[71],"in":[72,82,90,162,227],"vivo.":[73],"Synergistic":[74],"proliferation":[77],"inhibitor":[81],"clinical":[83],"development,":[84],"MK1775,":[85],"cytarabine":[87,150,158,226],"was":[88,159],"observed":[89],"all":[91],"acute":[92],"myelogenous":[93],"(AML)":[95],"cell":[96,125,182],"lines":[97,183],"tested,":[98],"regardless":[99],"functionality.":[102],"Mechanistic":[103],"studies":[104],"indicate":[105],"abrogates":[110],"the":[111,134,166,195],"S-phase":[112],"checkpoint":[113],"augments":[115],"apoptosis":[116],"induced":[117],"In":[120],"AML":[121,146],"lung":[123],"cancer":[124],"lines,":[126],"genetic":[127],"disruption":[128],"did":[131],"not":[132],"alter":[133],"cells'":[135],"enhanced":[136,165],"sensitivity":[137],"antimetabolites":[139],"inhibition.":[142],"Finally,":[143],"mice":[144,163],"were":[147],"treated":[148],"and/or":[151,215],"MK1775.":[152],"The":[153],"combination":[154],"MK1775":[156,224],"well":[160],"tolerated":[161],"antileukemia":[167],"effects":[168],"cytarabine,":[170],"including":[171],"survival.":[172],"hematologic":[178],"solid":[180],"tumor":[181],"antimetabolite":[185],"chemotherapeutics,":[186],"or":[191],"not,":[192],"suggesting":[193],"use":[196],"mutation":[199],"predictive":[202],"biomarker":[203],"response":[205],"may":[209],"be":[210],"restricted":[211],"certain":[213],"cancers":[214],"chemotherapeutics.":[216],"These":[217],"provide":[219],"preclinical":[220],"justification":[221],"testing":[223],"patients":[228],"leukemia.":[230]},"counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":6},{"year":2024,"cited_by_count":17},{"year":2023,"cited_by_count":8},{"year":2022,"cited_by_count":9},{"year":2021,"cited_by_count":9},{"year":2020,"cited_by_count":13},{"year":2019,"cited_by_count":9},{"year":2018,"cited_by_count":11},{"year":2017,"cited_by_count":16},{"year":2016,"cited_by_count":8},{"year":2015,"cited_by_count":9},{"year":2014,"cited_by_count":9}],"updated_date":"2026-10-28T10:33:24.094632","created_date":"2016-06-24T00:00:00"}